72
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Synthesis, characterization, and in vivo efficacy evaluation of PGG–docetaxel conjugate for potential cancer chemotherapy

, , , , , , & show all
Pages 581-589 | Published online: 03 Feb 2012

References

  • HeoJHParkSJKangJHDevelopment of new efficient synthetic methods for docetaxelBull Korean Chem Soc2009302526
  • PallisAGAgelakiSAgelidouAA randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic non-small cell lung cancerBMC Cancer20101063321092076
  • TannockIFde WitRBerryWRTAX 327 InvestigatorsDocetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancerN Engl J Med20043511502151215470213
  • HarveyVMouridsenHSemiglazovVPhase III trial comparing three doses of docetaxel for second-line treatment of advanced breast cancerJ Clin Oncol200644963497017033039
  • KudohSTakedaKNakagawaKPhase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)J Clin Oncol2006243657366316877734
  • SchuetteWNagelSBlankenburgTPhase III study of second-line chemotherapy for advanced non-small-cell lung cancer with weekly compared with 3-weekly docetaxelJ Clin Oncol2005238389839516293869
  • OkadaSSakataYMatsunoSPhase II study of docetaxel in patients with metastatic pancreatic cancer: a Japanese cooperative study. Cooperative Group of Docetaxel for Pancreatic Cancer in JapanBr J Cancer19998043844310408850
  • SulkesASmythJSessaCDocetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials GroupBr J Cancer1994703803837914428
  • Ten TijeAJVerweijJLoosWJSparreboomAPharmacological effects of formulation vehicles : implications for cancer chemotherapyClin Pharmacokinet20034266568512844327
  • YanasarnNSloatBRCuiZNanoparticles engineered from lecithin-in- water emulsions as a potential delivery system for docetaxelInt J Pharm200937917418019524029
  • ZhaiGWuJYuBGuoCYangXLeeRJA transferrin receptor-targeted liposomal formulation for docetaxelNanosci Nanotechnol20101051295136
  • ImmordinoMLBrusaPArpiccoSStellaBDosioFCattelLPreparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxelJ Control Release20039141742912932719
  • HwangHYKimISKwonICKimYHTumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticlesJ Control Release2008128233118374444
  • OstacoloLMarraMUngaroFIn vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsiloncaprolactone) block copolymers: Do nanocarrier properties have a role?J Control Release.2010148255263 Epub September 8, 201020816710
  • GaucherGMarchessaultRHLerouxJCPolyester-based micelles and nanoparticles for the parenteral delivery of taxanesJ Control Release201014321219925835
  • LiuBYangMLiRThe antitumor effect of novel docetaxel-loaded thermosensitive micellesEur J Pharm Biopharm20086952753418359617
  • XuZChenLGuWThe performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinomaBiomaterials200930226232 Epub October 11, 200818851881
  • LiuDWangLLiuZZhangCZhangNPreparation, characterization, and in vitro evaluation of docetaxel-loaded poly(lactic acid)-poly(ethylene glycol) nanoparticles for parenteral drug deliveryJ Biomed Nanotechnol2010667568221361132
  • SundaramSDurairajCKadamRKompellaUBLuteinizing hormone-releasing hormone receptor-targeted deslorelin–docetaxel conjugate enhances efficacy of docetaxel in prostate cancer therapyMol Cancer Ther2009816551665 Epub June 9, 200919509261
  • FiteAGouaMWahleKWSchofieldACHutcheonAWHeysSDPotentiation of the anti-tumour effect of docetaxel by conjugated linoleic acids (CLAs) in breast cancer cells in vitroProstaglandins Leukot Essent Fatty Acids200777879617900885
  • EsmaeiliFDinarvandRGhahremaniMHDocetaxel–albumin conjugates: preparation, in vitro evaluation and biodistribution studiesJ Pharm Sci2009982718273018972321
  • LeeEKimHLeeIHJonSIn vivo antitumor effects of chitosan-conjugated docetaxel after oral administrationJ Control Release2009140798519712714
  • EtrychTSírováMStarovoytovaLRíhováBUlbrichKHPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug releaseMol Pharm201071015102620518512
  • BrancoMCSchneiderJPSelf-assembling materials for therapeutic deliveryActa Biomater2009581783119010748
  • VanSDasSKWangXSynthesis, characterization, and biological evaluation of poly(L-γ-glutamyl-glutamine)-paclitaxel nanoconjugateInt J Nanomedicine2010582583721042550
  • WangXZhaoGVanSPharmacokinetics and tissue distribution of PGG–PTX, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenograftsCancer Chemother Pharmacol20106551552619593566
  • FengZZhaoGYuLGoughDHowellSBPreclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that outperforms AbraxaneCancer Chemother Pharmacol201065923930 Epub August 15, 200919685054
  • YessineMALafleurMMeierCPetereitHULerouxJCCharacterization of the membrane-destabilizing properties of different pH-sensitive methacrylic acid copolymersBiochim Biophys Acta20031613283812832084
  • MaedaHWuJSawaTMatsumuraYHoriKTumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJ Control Release2000291723
  • FoxMESzokaFCFréchetJMSoluble polymer carriers for the treatment of cancer: the importance of molecular architectureAcc Chem Res2009421141115119555070
  • DuncanRThe dawning era of polymer therapeuticsNat Rev Drug Discov2003234736012750738
  • HaagRKratzFPolymer therapeutics: concepts and applicationsAngew Chem Int Ed20064511981215
  • O’BrienMERSocinskiMAPopovichAYRandomized phase iii trial comparing sing-agent paclitaxel Poliglumex (CT-2103, PPX) with single-agent gemcitabine or vinorelbine for the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancerJ Thorac Oncol2008372873418594318
  • Paz-AresLRossHO’BrienMPhase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancerBr J Cancer2008981608161318475293
  • LangerCJO’ByrneKJSocinskiMAPhase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancerJ Thorac Oncol2008362363018520802
  • YangDVanSLiuJPhysicochemical properties and biocompatibility of polymer–paclitaxel conjugate for cancer treatmentInt J Nanomedicine2011625572566 Epub October 21, 201122072890
  • YangDVanSJiangXYuLNovel free paclitaxel-loaded poly(L-γ-glutamylglutamine)-paclitaxel nanoparticlesInt J Nanomedicine20116859121289985
  • KwonSParkJHChungHKwonICJeongSYKimISPhysicochemical characteristics of self-assembled nanoparticles based on glycol chitosan bearing 5-cholanic acidLangmuir2003191018810193